CORONA — Corona Remedies Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹84.05bn
- IN₹84.06bn
- IN₹11.96bn
Annual cashflow statement for Corona Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 1,109 | 1,185 | 1,985 |
| Depreciation | |||
| Non-Cash Items | 24.5 | 186 | 151 |
| Unusual Items | |||
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -307 | -85.9 | -603 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | 1,027 | 1,568 | 1,905 |
| Capital Expenditures | -948 | -2,863 | -916 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 445 | 197 | 78.1 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -502 | -2,666 | -838 |
| Financing Cash Flow Items | -113 | -314 | -328 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -447 | 985 | -1,066 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 76.7 | -113 | 0.67 |